Trials / Withdrawn
WithdrawnNCT01124825
Use of New Supraglottic Airway Devices in Severely Obese Patients: A Feasibility Study
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Louisville · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether two new airway devices used during anesthesia called iGEL™ and KING-LTS-DTM work well and are safe in obese patients. They both work well in thin patients, but have not been tested in obese patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | IGEL | iGEL(TM) airway will be used for induction and maintenance of positive pressure ventilation |
| DEVICE | King airway | KING-LTS-D(TM) airway will be used for induction and maintenance of positive pressure ventilation |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-05-01
- Completion
- 2012-10-01
- First posted
- 2010-05-17
- Last updated
- 2012-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01124825. Inclusion in this directory is not an endorsement.